| Demographic data - Admission |
Record ID, Date of admission, Form of admission, Last name, Name, Middle name, Number of the National Health Card (CNS), SAME, Date of birth, Age, Race, Gender, Address, City |
DATASUS, IBGE, STS |
| Preoperative risk factors, Preoperative heart status, Preoperative drugs |
Record ID, Weight, Height, BMI, Smoker, Current smoker, Diabetes, Diabetes control, Dyslipidemia, Dyslipidemia control, Kidney failure, Dialysis, Hypertension, Stroke, Time since stroke, Infectious endocarditis, Type of endocarditis, Pulmonary disease, Immunosuppressing therapy, Peripheral vascular disease, Cerebrovascular disease, AMI, Time AMI, Heart failure last 2 weeks, CHF, Heart condition at admission, Cardiogenic shock, Cardiac resuscitation, Arrhythmia, Type of arrhythmia, NYHA, Beta blockers, Use of BB 2 weeks, ACE-inhibitor, Nitrates, Anticoagulation, Name anticoagulant, Warfarin, IV Inotropes, Corticoids, Aspirin, Adenosine diphosphate (ADP) receptor inhibitors , Adenosine diphosphate (ADP) receptor inhibitors 24 hours before , Glycoprotein IIb/IIIa, Number of compromised vases, Percentage main stenosis left side vase, EF measure, EF, Presence of valvopathy, Aortic failure, Aortic stenosis, Mitral failure, Mitral stenosis, Tricuspid failure, Pulmonary failure, Incidence of surgery, Status, IABP, Ht, Hb, Na, K, Urea, Creatinine, Glucose, Platelets, TP, TTPA |
ACCF, NCDR, STS |
| Intraoperative |
Record ID, Name of surgeon, Surgery category, Use of robotic technology, Minimally invasive procedure, Conversion to standard procedure, Use of ECC, Use of arterial filter, Strategy of acid-base management, Bioactive coating area, Type of system, Assistance in venous draining, Type of arterial pump, Use of autotransfusion Pulsatile Perfusion device, Saline solution filling volume, Ringer lactate filling volume, Plasma-Lyte filling volume, Albumin 5% filling volume, Albumin 25% filling volume, Starch solution filling volume, Mannitol filling volume, Sodium bicarbonate filling volume, Red cells concentrates in priming, Plasma in priming, Heparin dose, Total volume of priming, Time of perfusion, Type of aorta clamping, Site of aorta clamping, Time of aorta occlusion or clamping, Circulatory arrest (CA), Time of CA, Selective cerebral perfusion (SCP), Time of SCP, Time of reperfusion, Return to ECC, Reasons for returning to ECC, Cardioplegia, Type of cardioplegia, Regimen of cardioplegia, Temperature of cardioplegia induction, Direction of cardioplegia induction flow, Temperature of cardioplegia maintenance, Direction of cardioplegia maintenance flow, Total volume of cardioplegia, Assessment of the presence of preexistent calcifications in the site of aorta handling, Aorta classification, Site of temperature measurement, Lower temperature reached in the nasopharyngeal path, Lower temperature reached in the esophageal path, Lower temperature reached in the jugular bulb region |
STS, PERForm |
|
|
Lower temperature reached in the rectal path, Lower tympanic temperature reached, Lower temperature reached in other paths, Higher temperature reached in the nasopharyngeal path, Higher temperature reached in the esophageal path, Higher temperature reached in the jugular bulb region, Higher temperature reached in the rectal path, Higher tympanic temperature reached, Higher temperature reached in other paths, Temperature following ECC, Initial Hematocrit (Ht) in ECC, Initial hemoglobin (Hb) in ECC, Hematocrit (Ht) when leaving the surgery room, Hemoglobin (Hb) when leaving the surgery room, Intra-Aortic Balloon Pump (IABP) in the surgery room, Period of insertion of IABP in the surgery room, Indication of IABP in the surgery room, Use of hemoderivatives, Use of red cells concentrate, Use of fresh frozen plasma, Use of platelets, Use of cryoprecipitate, Fibrinogen concentrate was administered, Prothrombin complex concentrate was administered , Administered dose of fibrinogen concentrate, Administered dose of prothrombin complex concentrate , Volume of SS 0.9% used in ECC, Volume of Ringer lactate used in ECC, Volume of Plasma-Lyte used in ECC, Volume of Albumin 5% used in ECC, Volume of Albumin 25% used in ECC, Volume of Starch Solution used in ECC, Use of UF, Total UF volume, Volume of residual blood that returned to the patient, Volume of urine in the intraoperative period Presence of hemoglobin, Inotropic in use in the transfer to the ICU, Myocardial revascularization surgery Number of distal anastomoses with arterial graft, Number of distal anastomoses with venous graft, Number of distal anastomoses with internal mammary artery graft, Number of distal anastomoses with radial artery graft, |
|
| Number of distal anastomoses with Gastroepiploic artery graft, Number of anastomoses with other arterial grafts, Procedure in the aortic valve, Procedure in the mitral valve, Procedure in the tricuspid valve, Procedure in the pulmonary valve, Correction of aorta aneurysm, surgery of congenital cardiopathy, Surgery of aorta dissection correction, Other cardiovascular surgeries, Extubation in the surgery room |
| ICU discharge |
Record ID |
|
| Date and time of entrance at ICU, Date and time of discharge from ICU, Reintubation, Additional hours in MV, Total hours in MV, creatinine, hemoderivatives, units of red blood concentrate, Units of fresh frozen plasma, units of platelets, units of cryoprecipitate, Hematocrit at discharge, Hemoglobin at discharge, Echocardiogram, Presence of aortic valve failure, Presence of mitral valve failure, Presence of tricuspid valve failure, Presence of pulmonary valve failure, EF, Cardiac enzymes, Higher CKMB value measured, Higher Troponin value measured, Higher Troponin T value measured, ECG result, surgical intervention, Reintervention for bleeding, Date of intervention for bleeding, Intervention for valve dysfunction, Reintervention for coronary occlusion, Reintervention for other cardiac reasons, Reintervention for other non-cardiac reasons, complication in PO, Deep infection of the sternum, Infection of thoracotomy, Infection of OW in the site of grafts removal, Sepsis, Stroke, TIS, Prolonged mechanical ventilation (MV), Pneumonia, Infection in the urinary tract, Kidney failure, Dialysis, Deep vein thrombosis (DVT), Pulmonary thromboembolism |
ACCF, NCDR, STS, PERForm |
|
|
Limb ischemia, Myocardial infarction , Rhythm dysfunction requiring device, PCR, Events related to anticoagulant therapy, GI, Dysfunction of multiple organs, Atrial fibrillation / flutter, Injury of the laryngeal nerve, Injury of the phrenic nerve, Other events, Identification of the event, ACE-inhibitor, Beta blockers, Nitrates, Anticoagulants, Name of anticoagulant, Warfarin, IV Inotropes, Corticoids, Acetylsalicylic acid, Adenosine diphosphate (ADP) receptor inhibitors , Glycoprotein IIb/IIIa |
|
| Hospital discharge |
Patient status, Date and time of the hospital discharge, Date and time of death, Cause of death, Units of red cell concentrate, Units of fresh frozen plasma, Units of platelets, Units of Cryoprecipitate, Echocardiogram, Presence of aortic valve failure, Presence of mitral valve failure, Presence of tricuspid valve failure, Presence of pulmonary valve failure, EF, PO complications, Deep infection of the sternum, Infection of the thoracotomy, Infection of the OW in the site of the grafts removal, Sepsis, stroke, TIS, Prolonged mechanical ventilation (MV), Pneumonia, Infection in the urinary tract, Kidney failure, Dialysis, Deep vein thrombosis (DVT), Pulmonary thromboembolism, Limb ischemia, myocardial infarction , Rhythm dysfunction requiring device, PCR, Events related to anticoagulant therapy, GI, Dysfunction of multiple organs, Atrial fibrillation / flutter, Injury of the laryngeal nerve, Injury of the phrenic nerve, Other events, Identification of the event, ACE-inhibitor, Beta blockers, Nitrates, Anticoagulants, Name of the anticoagulant, Warfarin, IV Inotropes, Corticoids, Acetylsalicylic acid, Adenosine diphosphate (ADP) receptor inhibitors , Glycoprotein IIb/IIIa |
ACCF, NCDR, STS, PERForm |
| Follow-up One month Six months One year Two years Three years Four years Five years |
Patient status, Date of hospital discharge, Hospitalization, Still hospitalized, Days of permanence in the ICU, Date and time of death, Cause of death, Complications, Deep infection of the sternum, Infection of the thoracotomy, Infection of the OW in the site of the grafts removal, Sepsis, stroke, TIS, Prolonged mechanical ventilation (MV), Pneumonia, Infection in the urinary tract, Kidney failure, Dialysis, Deep vein thrombosis (DVT), Pulmonary thromboembolism, Limb ischemia, myocardial infarction , Rhythm dysfunction requiring device, PCR, Events related to anticoagulant therapy, GI, Dysfunction of multiple organs, Atrial fibrillation / flutter, Injury of the laryngeal nerve, Injury of the phrenic nerve, Other events, Identification of the event, ACE-inhibitor, Beta blockers, Nitrates, Anticoagulants, Name of the anticoagulant, Warfarin, IV Inotropes, Corticoids, Acetylsalicylic acid, Adenosine diphosphate (ADP) receptor inhibitors , Glycoprotein IIb/IIIa |
ACCF, NCDR, STS, PERForm |
